Trademark Overview
On Monday, January 5, 2026, a trademark application was filed for NEXQLAD with the United States Patent and Trademark Office. The USPTO has given the NEXQLAD trademark a serial number of 99578125. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, January 5, 2026. This trademark is owned by AstraZeneca AB. The NEXQLAD trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines; Antibodies for medical purposes